Pharmacopeia shares rise on blood pressure study - Boston Globe
NEW ORLEANS Pharmacopeia Inc. said Friday data from a midstage study showed its PS433540 experimental drug significantly reduced blood pressure in patients with mild to moderate hypertension. PS433540 is being developed as a potential treatment …
